GENE ONLINE|News &
Opinion
Blog

B-cell Lymphoma
Canada Authorizes Roche’s Polivy as First-Line Lymphoma Treatment
2022-11-27
CHMP Gives Kite’s Lymphoma Immunotherapy a Positive Opinion
2022-09-16
AstraZeneca Buys TeneoTwo in $1.2 Billion T-Cell Engager Play
2022-07-06
Bristol Myers’ Breyanzi Now FDA-Approved for Earlier Lymphoma
2022-06-27
Daiichi Sankyo Authorizes First Yescarta Treatment Site in Japan
2021-12-17
Hot Pursuit for Antibody Drug Conjugates Continue as Merck Acquires VelosBio
2020-11-06
Aiming for the First CAR-T Approval in China, JW Therapeutics Debuts on Hong Kong Stock Exchange
2020-11-04
Daiichi Sankyo Seeks Yescarta Approval in Japan for Relapsed or Refractory B-cell Lymphoma
2020-04-01
LATEST
Forced Migrants in Ukraine Face Barriers to HIV and TB Care Amid Disrupted Healthcare Systems
2026-01-23
Residual Cardiovascular Risk Persists in Coronary Artery Disease Despite Advances in Treatment
2026-01-23
Advocacy-Informed Research and PRISM Framework Highlighted in Healthcare Policy Reform Strategies
2026-01-23
Study Explores Link Between Red Blood Cell Distribution Width and Prognosis in Peripheral T-Cell Lymphoma
2026-01-23
Study Finds Jackdaw Contact Calls Exhibit Individual Variability for Social Communication
2026-01-23
Study Analyzes Measles Infection Trends Among Children in Togo from 2020 to 2024
2026-01-23
Study in Thailand Finds Higher Osteoporosis Rates Among Type 2 Diabetes Patients
2026-01-23
EVENT
2026-02-09
World Health Expo Dubai
Dubai Exhibition Centre, Dubai
2026-02-17
BIO Asia 2026 (Life Science Partnerships)
Hyderabad, India
2026-02-24
Rare Disease Week on Capitol Hill (Policy and Advocacy)
Capitol Hill, Washington, D.C.
2026-03-09
HIMSS26 (Digital Health & Hospital IT)
Las Vegas, Nevada
2026-03-23
BIO Europe Spring (Biotech Partnering)
Lisbon, Portugal
Scroll to Top